Arrowhead Pharmaceuticals Inc (ARWR)

85.05 +3.30  +4.04% NASDAQ Feb 24, 16:59 USD
View Full Chart
Price Chart
View All ARWR News

News

View All Events

Events

Date Type Description
05/07/2021 Earnings Arrowhead Pharmaceuticals Inc Second Quarter Earnings Results for 2021
05/07/2021 Misc Arrowhead Pharmaceuticals Inc Second Quarter Earnings Conference Call for 2021
02/04/2021 Earnings Arrowhead Pharmaceuticals Inc First Quarter Earnings Result for 2021
02/04/2021 16:30 EST Misc Arrowhead Pharmaceuticals Inc First Quarter Earnings Conference Call for 2021
11/23/2020 Earnings Arrowhead Pharmaceuticals Inc Fourth Quarter Earnings Result for 2020
11/23/2020 16:30 EST Misc Arrowhead Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 2020
11/23/2020 Misc Arrowhead Pharmaceuticals Inc Annual Report for 2020
08/05/2020 16:30 EDT Misc Arrowhead Pharmaceuticals Inc Third Quarter Earnings Conference Call for 2020
08/05/2020 Earnings Arrowhead Pharmaceuticals Inc Third Quarter Earnings Result for 2020
05/07/2020 16:30 EDT Misc Arrowhead Pharmaceuticals Inc Second Quarter Earnings Conference Call for 2020
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.arrowheadpharma.com
  • Investor Relations URL: http://ir.arrowheadpharma.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: May. 07, 2021
  • Last Earnings Release: Feb. 04, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

Top Fund Holders

Symbol Name Weighting
GNOM Global X Genomics & Biotechnology ETF 4.26%
GOFFX Invesco Global Opp R5 2.47%
BIOUX Baron Opportunity R6 1.82%
FBIOX Fidelity® Select Biotechnology 1.03%
JKK iShares Morningstar Small-Cap Growth ETF 0.90%
IWO iShares Russell 2000 Growth ETF 0.61%
VTWG Vanguard Russell 2000 Growth ETF 0.57%
VTWO Vanguard Russell 2000 ETF 0.31%
IWM iShares Russell 2000 ETF 0.30%
FSSNX Fidelity® Small Cap Index 0.30%
VRTIX Vanguard Russell 2000 Index I 0.30%
SWSSX Schwab Small Cap Index 0.29%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.